Hsiu-Yi Chin, Chen-Yu Kao, Kun-Lun Huang, Shiao-Pieng Lee
{"title":"Decellularized lung extracellular matrix-assisted delivery of mesenchymal stem cell-derived extracellular vesicles in acute lung injury.","authors":"Hsiu-Yi Chin, Chen-Yu Kao, Kun-Lun Huang, Shiao-Pieng Lee","doi":"10.1177/08853282261496666","DOIUrl":null,"url":null,"abstract":"<p><p>Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutics for inflammatory and tissue injury. However, their pulmonary application may be limited by rapid redistribution and the lack of a tissue-specific microenvironment. In this study, lung-derived decellularized extracellular matrix (dECM) was investigated as a biologically relevant matrix for pulmonary delivery of MSC-derived extracellular vesicles. The physicochemical characteristics of the extracellular vesicles were evaluated using nanoparticle tracking analysis (NTA), dynamic light scattering (DLS), scanning electron microscopy (SEM), and cryogenic electron microscopy (Cryo-EM). To examine early pulmonary localization, Coumarin-6-labeled extracellular vesicles were administered intratracheally, and frozen lung sections were examined 2 h after administration. Free Coumarin-6 produced a diffuse fluorescence pattern, whereas labeled extracellular vesicles exhibited discrete punctate fluorescence. The dECM-containing formulation showed a more clustered fluorescence pattern, suggesting altered local distribution of extracellular vesicle-associated material within the lung. In vitro, MSC-EVs reduced TNF-α production by activated THP-1-derived macrophages without detectable cytotoxicity in L929 cells. In a lipopolysaccharide (LPS)-induced rat model of acute lung injury, extracellular vesicle treatment reduced TNF-α and increased IL-10 in bronchoalveolar lavage fluid, accompanied by partial preservation of lung architecture. Notably, ECM-assisted extracellular vesicle treatment produced a greater reduction in MMP-9 and a more favorable MMP-9/TIMP-1 ratio than extracellular vesicles alone. These findings suggest that lung-derived dECM can provide a biologically relevant matrix environment for pulmonary extracellular vesicle delivery and may contribute to modulation of extracellular matrix remodeling during early acute lung injury. Further studies using quantitative biodistribution, longitudinal retention, release kinetics, and cellular uptake analyses are warranted to establish the mechanisms underlying dECM-assisted extracellular vesicle delivery.</p>","PeriodicalId":15138,"journal":{"name":"Journal of Biomaterials Applications","volume":" ","pages":"8853282261496666"},"PeriodicalIF":2.4000,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomaterials Applications","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/08853282261496666","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have emerged as promising cell-free therapeutics for inflammatory and tissue injury. However, their pulmonary application may be limited by rapid redistribution and the lack of a tissue-specific microenvironment. In this study, lung-derived decellularized extracellular matrix (dECM) was investigated as a biologically relevant matrix for pulmonary delivery of MSC-derived extracellular vesicles. The physicochemical characteristics of the extracellular vesicles were evaluated using nanoparticle tracking analysis (NTA), dynamic light scattering (DLS), scanning electron microscopy (SEM), and cryogenic electron microscopy (Cryo-EM). To examine early pulmonary localization, Coumarin-6-labeled extracellular vesicles were administered intratracheally, and frozen lung sections were examined 2 h after administration. Free Coumarin-6 produced a diffuse fluorescence pattern, whereas labeled extracellular vesicles exhibited discrete punctate fluorescence. The dECM-containing formulation showed a more clustered fluorescence pattern, suggesting altered local distribution of extracellular vesicle-associated material within the lung. In vitro, MSC-EVs reduced TNF-α production by activated THP-1-derived macrophages without detectable cytotoxicity in L929 cells. In a lipopolysaccharide (LPS)-induced rat model of acute lung injury, extracellular vesicle treatment reduced TNF-α and increased IL-10 in bronchoalveolar lavage fluid, accompanied by partial preservation of lung architecture. Notably, ECM-assisted extracellular vesicle treatment produced a greater reduction in MMP-9 and a more favorable MMP-9/TIMP-1 ratio than extracellular vesicles alone. These findings suggest that lung-derived dECM can provide a biologically relevant matrix environment for pulmonary extracellular vesicle delivery and may contribute to modulation of extracellular matrix remodeling during early acute lung injury. Further studies using quantitative biodistribution, longitudinal retention, release kinetics, and cellular uptake analyses are warranted to establish the mechanisms underlying dECM-assisted extracellular vesicle delivery.
期刊介绍:
The Journal of Biomaterials Applications is a fully peer reviewed international journal that publishes original research and review articles that emphasize the development, manufacture and clinical applications of biomaterials.
Peer-reviewed articles by biomedical specialists from around the world cover:
New developments in biomaterials, R&D, properties and performance, evaluation and applications
Applications in biomedical materials and devices - from sutures and wound dressings to biosensors and cardiovascular devices
Current findings in biological compatibility/incompatibility of biomaterials
The Journal of Biomaterials Applications publishes original articles that emphasize the development, manufacture and clinical applications of biomaterials. Biomaterials continue to be one of the most rapidly growing areas of research in plastics today and certainly one of the biggest technical challenges, since biomaterial performance is dependent on polymer compatibility with the aggressive biological environment. The Journal cuts across disciplines and focuses on medical research and topics that present the broadest view of practical applications of biomaterials in actual clinical use.
The Journal of Biomaterial Applications is devoted to new and emerging biomaterials technologies, particularly focusing on the many applications which are under development at industrial biomedical and polymer research facilities, as well as the ongoing activities in academic, medical and applied clinical uses of devices.